Brain Cancer Bevacizumab vs. Concurrent Bevacizumab and re-RT for Recurrent GBM: Phase II Trial Mar 13, 2023
Colorectal Cancer,Gastrointestinal Cancer Breakwater Safety Lead-In Improves Outcomes in BRAFV600E mCRC Mar 13, 2023
Colorectal Cancer,Gastrointestinal Cancer Global Study Shows Fruquintinib Improves HRQoL in FRESCO-2 Trial Mar 13, 2023
Colorectal Cancer,Gastrointestinal Cancer EPOCH Trial: Optimizing Treatment Planning for Patient Subgroups Mar 13, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Ibrutinib Improves OS in CLL Patients ≥65 Years as First-Line Treatment Mar 10, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia 4-Year Follow-Up Data of Ibrutinib and Venetoclax Combo in CLL Patients Mar 10, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Comparing Venetoclax and Chemoimmunotherapy for CLL: GAIA/CLL13 Phase 3 Trial Mar 10, 2023
